Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- COX G. H., MARLEY E. The estimation of motility during rest or sleep. J Neurol Neurosurg Psychiatry. 1959 Feb;22(1):57–60. doi: 10.1136/jnnp.22.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FOLTZ E. L., DRACOS F., GRUBER C. M., Jr A comparison of the hypnotic effects of chloral and ethinamate. Am J Med Sci. 1955 Nov;230(5):528–535. doi: 10.1097/00000441-195523050-00008. [DOI] [PubMed] [Google Scholar]
- GARDNER A. Meprobamate; a clinical study. Am J Psychiatry. 1957 Dec;114(6):524–526. doi: 10.1176/ajp.114.6.524. [DOI] [PubMed] [Google Scholar]
- GOODNOW R. E., BEECHER H. K., BRAZIER M. A. B., MOSTELLER K., TAGIURI R. Physiological performance following a hypnotic dose of a barbiturate. J Pharmacol Exp Ther. 1951 May;102(1):55–61. [PubMed] [Google Scholar]
- HARE E. H. Comparative efficacy of hypnotics a self-controlled, self-recorded clinical trial in neurotic patients. Br J Prev Soc Med. 1955 Jul;9(3):140–146. doi: 10.1136/jech.9.3.140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HINTON J. M., MARLEY E. The effects of meprobamate and pentobarbitone sodium on sleep and motility during sleep: a controlled trial with psychiatric patients. J Neurol Neurosurg Psychiatry. 1959 May;22(2):137–140. doi: 10.1136/jnnp.22.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HINTON J. M. The actions of amylobarbitone sodium, butobarbitone and quinalbarbitone sodium upon insomnia and nocturnal restlessness compared in psychiatric patients. Br J Pharmacol Chemother. 1961 Feb;16:82–89. doi: 10.1111/j.1476-5381.1961.tb00300.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HOWELL T. H. Sedation and analgesia in old age. Practitioner. 1960 Jan;184:45–48. [PubMed] [Google Scholar]
- IMBODEN J., LASAGNA L. An evaluation of hypnotic drugs in psychiatric patients. Bull Johns Hopkins Hosp. 1956 Aug;99(2):91–100. [PubMed] [Google Scholar]
- ISAACS B. A method for evaluation of hypnotic drugs. Lancet. 1957 Mar 16;272(6968):556–558. doi: 10.1016/s0140-6736(57)90922-4. [DOI] [PubMed] [Google Scholar]
- KESSLER L. N., BARNARD R. D. A new tranquilizer, meprobamate; its use for pain associated with cancer; preliminary report. Med Times. 1956 Apr;84(4):431–435. [PubMed] [Google Scholar]
- LASAGNA L. A comparison of hypnotic agents. J Pharmacol Exp Ther. 1954 May;111(1):9–20. [PubMed] [Google Scholar]
- LLEWELLYN A. Management of confusion and restlessness in the aged. Br J Clin Pract. 1961 Oct;15:839–842. [PubMed] [Google Scholar]
- SELLING L. S. A clinical study of Miltown, a new tranquilizing agent. J Clin Exp Psychopathol. 1956 Jan-Mar;17(1):7–14. [PubMed] [Google Scholar]
- STEWART J. S. Clinical trial of methyprylone, a piperidine hypnotic. Br Med J. 1956 Dec 22;2(5007):1465–1467. doi: 10.1136/bmj.2.5007.1465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- STRAUS B., EISENBERG J., GENNIS J. Hypnotic effects of an antihistamine; methapyrilene hydrochloride. Ann Intern Med. 1955 Mar;42(3):574–582. doi: 10.7326/0003-4819-42-3-574. [DOI] [PubMed] [Google Scholar]
- VON FELSINGER J. M., LASAGNA L., BEECHER H. K. The persistence of mental impairment following a hypnotic dose of a barbiturate. J Pharmacol Exp Ther. 1953 Nov;109(3):284–291. [PubMed] [Google Scholar]